Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 10, 2024FEBS Journal

Depletion of SASP senescent cardiomyocytes with senolytic drugs confers therapeutic effects in doxorubicin‐related cardiotoxicity

View Full Paper
Ask AI
Bookmark
Share

Authors

WXWenzheng XiaHCHanbin ChenYHYang Han

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xia et al. (2024) studied this question.

synapsesocial.com/papers/68e65665b6db6435875e50d9https://doi.org/10.1111/febs.17164
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MicroRNA therapy confers anti-senescent effects on doxorubicin-related cardiotoxicity by intracellular and paracrine signaling2021 · 19 citations
  2. 2Mechanisms of Doxorubicin-Induced Cardiac Senescence and Potential Therapeutic Strategies2026
  3. 3SS-31 Attenuates Doxorubicin-induced Cardiomyoblast H9C2 Cell Senescence2024
  4. 4Cellular Senescence Mediates Doxorubicin Chemotherapy-Induced Aortic Stiffening: Role of Glycation Stress2025
  5. 5The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity2021 · 26 citations